The weight loss medication market moves fast. This week brings fresh guidance on safe use, new oral options, and a stronger focus on muscle health. Here is what matters right now for patients in Surrey and beyond.
Oral tablets are now a real choice
Injections led the way for years. Now daily pills give people an alternative. In the UK, the MHRA approved the Wegovy pill, oral semaglutide, on 11 June 2026, the country’s first weight loss tablet. In the United States, the regulator has approved Eli Lilly’s orforglipron, sold as Foundayo, another daily GLP-1 pill. These suit anyone who prefers tablets over weekly jabs. Early results show solid weight loss when the medication is paired with diet and activity. For many patients, a tablet removes one barrier to starting treatment.
Strength training is now official advice for jab users
The UK’s chief medical officers and other experts make one point clearly. People on weight loss jabs should add resistance training. An estimated 1.5 to 2.5 million people in the UK now use these medications. Without strength work, they risk losing muscle as well as fat, which can slow metabolism and affect strength over time. Current guidance points to two or three strength sessions a week alongside regular activity.
- Two or three short strength sessions a week, using dumbbells, resistance bands, or bodyweight.
- Enough daily protein to support and protect muscle.
- Regular walking and movement across the day.
Combine these habits and you hold on to better results. At Easy Pharmacy we can advise on how to support your treatment with the right routine.
Access programmes expand in the United States
The new Medicare GLP-1 Bridge started on 1 July 2026. Eligible patients pay $50 a month for certain approved treatments, including the Wegovy pill and injection, Zepbound, and Foundayo. It runs to the end of 2027 and could reach millions more people. In the UK, most use remains private, but demand stays high.
Regulators tighten rules on unlicensed versions
As national shortages of the branded products have eased, authorities are limiting large-scale compounding of semaglutide and tirzepatide. The focus is on safety and quality. Patients get the best and safest outcomes from legitimate, approved supplies through proper channels like Easy Pharmacy.
What this means for patients at Easy Pharmacy
These medicines work best with lifestyle changes. Oral options remove one barrier. Strength training protects your results. Safe supply through a trusted pharmacy remains essential. Easy Pharmacy in Surrey offers professional support for weight management. We supply approved treatments with qualified advice, and we do not sell medication without a proper assessment. Our team helps you choose the right path.
Next steps
Speak to your doctor or our team at Easy Pharmacy before starting any treatment. Combine medication with diet, activity, and strength work for the best outcome. Stay informed as new pills and higher doses come forward.
Sources
- GOV.UK, first GLP-1 tablet for weight loss approved in the UK
- Drugs.com, Foundayo (orforglipron) FDA approval
- CMS, Medicare GLP-1 Bridge
- ukactive, weight-loss jabs and muscle mass
Easy Pharmacy is registered with the General Pharmaceutical Council (9011078). This article is general information and not medical advice. Prescription treatments are supplied only after a consultation and clinical assessment.